References

Abbasi, S., M. Noruzinia, O. Bashti, M. Ahmadvand, A. R. Salehi Chaleshtori, and L. Mahootipou. 2017. “Another Novel Missense Mutation in ARSB Gene in Iran.” Acta Medica Iranica 55(9):585–90.
Alaei, Mohammad Reza, Meghdad Kheirkhahan, Saeed Talebi, Elham Davoudi-Dehaghani, and Mohammad Keramatipour. 2020. “Once in a Blue Moon, a Very Rare Coexistence of Glutaric Acidemia Type I and Mucopolysaccharidosis Type IIIB in a Patient.” Iranian Biomedical Journal 24(3):201–5. doi: 10.29252/ibj.24.3.201.
Alif, N., K. Hess, J. Straczek, S. Sebbar, A. N’Bou, P. Nabet, and B. Dousset. 1999. “Mucopolysaccharidosis Type I: Characterization of a Common Mutation That Causes Hurler Syndrome in Moroccan Subjects.”Annals of Human Genetics 63(Pt 1):9–16. doi: 10.1046/j.1469-1809.1999.6310009.x [doi].
Al-Jasmi, F. A., N. Tawfig, A. Berniah, B. R. Ali, M. Taleb, J. L. Hertecant, F. Bastaki, and A. K. Souid. 2013. “Prevalence and Novel Mutations of Lysosomal Storage Disorders in United Arab Emirates : LSD in UAE.” JIMD Reports 10:1–9. doi: 10.1007/8904_2012_182 [doi].
Aminzadeh, M., N. Malekpour, and P. Ghandil. 2019. “Identification of Arylsulfatase B Gene Mutations and Clinical Presentations of Iranian Patients with Mucopolysaccharidosis VI.” Gene 706:1–5. doi: S0378-1119(19)30403-2 [pii].
Atceken, N., R. K. Ozgul, D. Yucel Yilmaz, A. Tokatli, T. Coskun, H. S. Sivri, A. Dursun, and M. Karaca. 2016. “Evaluation and Identification of IDUA Gene Mutations in Turkishpatients with Mucopolysaccharidosis Type I.” Turkish Journal of Medical Sciences 46(2):404–8. doi: 10.3906/sag-1411-160 [doi].
Bertola, F., M. Filocamo, G. Casati, M. Mort, C. Rosano, A. Tylki-Szymanska, B. Tuysuz, O. Gabrielli, S. Grossi, M. Scarpa, G. Parenti, D. Antuzzi, J. Dalmau, M. Di Rocco, C. Dionisi Vici, I. Okur, J. Rosell, A. Rovelli, F. Furlan, M. Rigoldi, A. Biondi, D. N. Cooper, and R. Parini. 2011. “IDUA Mutational Profiling of a Cohort of 102 European Patients with Mucopolysaccharidosis Type I: Identification and Characterization of 35 Novel Alpha-L-Iduronidase (IDUA) Alleles.”Human Mutation 32(6):2189. doi: 10.1002/humu.21479 [doi].
Bidchol, A. M., A. Dalal, H. Shah, S. S, S. Nampoothiri, M. Kabra, N. Gupta, S. Danda, K. Gowrishankar, S. R. Phadke, S. Kapoor, M. Kamate, I. C. Verma, R. D. Puri, V. H. Sankar, A. R. Devi, S. J. Patil, P. Ranganath, S. J. Jain, M. Agarwal, A. Singh, P. Mishra, P. M. Tamhankar, P. M. Gopinath, H. A. Nagarajaram, K. Satyamoorthy, and K. M. Girisha. 2014. “GALNS Mutations in Indian Patients with Mucopolysaccharidosis IVA.” American Journal of Medical Genetics.Part A164A(11):2793–2801. doi: 10.1002/ajmg.a.36735 [doi].
Brusius-Facchin, A. C., M. Siebert, D. Leao, D. R. Malaga, G. Pasqualim, F. Trapp, U. Matte, R. Giugliani, and S. Leistner-Segal. 2019. “Phenotype-Oriented NGS Panels for Mucopolysaccharidoses: Validation and Potential Use in the Diagnostic Flowchart.” Genetics and Molecular Biology 42(1 suppl 1):207–14. doi: S1415-47572019000200207 [pii].
Chkioua, L., S. Khedhiri, A. Kassab, A. Bibi, S. Ferchichi, R. Froissart, C. Vianey-Saban, S. Laradi, and A. Miled. 2011. “Molecular Analysis of Mucopolysaccharidosis Type I in Tunisia: Identification of Novel Mutation and Eight Novel Polymorphisms.” Diagnostic Pathology 6:39–39. doi: 10.1186/1746-1596-6-39 [doi].
Cobos, P. N., C. Steglich, R. Santer, Z. Lukacs, and A. Gal. 2015. “Dried Blood Spots Allow Targeted Screening to Diagnose Mucopolysaccharidosis and Mucolipidosis.” JIMD Reports15:123–32. doi: 10.1007/8904_2014_308 [doi].
Consortium, 1000 Genomes Project, G. R. Abecasis, D. Altshuler, A. Auton, L. D. Brooks, R. M. Durbin, R. A. Gibbs, M. E. Hurles, and G. A. McVean. 2010. “A Map of Human Genome Variation from Population-Scale Sequencing.” Nature 467(7319):1061–73. doi: 10.1038/nature09534 [doi].
Costa-Motta, F. M., F. Bender, A. Acosta, K. Abe-Sandes, T. Machado, T. Bomfim, T. Boa Sorte, D. da Silva, A. Bittles, R. Giugliani, and S. Leistner-Segal. 2014. “A Community-Based Study of Mucopolysaccharidosis Type VI in Brazil: The Influence of Founder Effect, Endogamy and Consanguinity.” Human Heredity 77(1–4):189–96. doi: 10.1159/000358404 [doi].
Eisenberger, T., C. Neuhaus, A. O. Khan, C. Decker, M. N. Preising, C. Friedburg, A. Bieg, M. Gliem, P. Charbel Issa, F. G. Holz, S. M. Baig, Y. Hellenbroich, A. Galvez, K. Platzer, B. Wollnik, N. Laddach, S. R. Ghaffari, M. Rafati, E. Botzenhart, S. Tinschert, D. Borger, A. Bohring, J. Schreml, S. Kortge-Jung, C. Schell-Apacik, K. Bakur, J. Y. Al-Aama, T. Neuhann, P. Herkenrath, G. Nurnberg, P. Nurnberg, J. S. Davis, A. Gal, C. Bergmann, B. Lorenz, and H. J. Bolz. 2013. “Increasing the Yield in Targeted Next-Generation Sequencing by Implicating CNV Analysis, Non-Coding Exons and the Overall Variant Load: The Example of Retinal Dystrophies.” PloS One 8(11):e78496. doi: 10.1371/journal.pone.0078496 [doi].
Filocamo, M., R. Tomanin, F. Bertola, and A. Morrone. 2018.Biochemical and Molecular Analysis in Mucopolysaccharidoses: What a Paediatrician Must Know . Vol. 44.
Fox, E. J., K. S. Reid-Bayliss, M. J. Emond, and L. A. Loeb. 2014. “Accuracy of Next Generation Sequencing Platforms.” Next Generation, Sequencing & Applications 1:10.4172/jngsa.1000106. doi: 1000106 [pii].
Ghaffari, Saeed Reza, and Maryam Rafati. 2020. “Iran Variome MPS Database.” Retrieved June 26, 2021 (https://variome.ir/lovd).
Harismendy, O., P. C. Ng, R. L. Strausberg, X. Wang, T. B. Stockwell, K. Y. Beeson, N. J. Schork, S. S. Murray, E. J. Topol, S. Levy, and K. A. Frazer. 2009. “Evaluation of next Generation Sequencing Platforms for Population Targeted Sequencing Studies.” Genome Biology10(3):R32-r32. Epub 2009 Mar 27. doi: 10.1186/gb-2009-10-3-r32 [doi].
Jafaryazdi, Rokhsareh, Sedigheh Shams, Anna Isaian, Aria Setoodeh, and Shahram Teimourian. 2019. “Identification of Eleven Different Mutations Including Six Novel, in the Arylsulfatase B Gene in Iranian Patients with Mucopolysaccharidosis Type VI.” Molecular Biology Reports46(3):3417–26. doi: 10.1007/s11033-019-04804-9.
Jafaryazdi, Rokhsareh, Sediqheh Shams, Anna Isaian, Emel Ebadi, Reza Safaralizadeh, and Shahram Teimourian. 2018. “A Novel Compound Heterozygote Mutation in the ARSB Gene in a Patient with Maroteaux-Lamy Syndrome and Its Insilico Evaluation.” Meta Gene 18:127–31. doi: https://doi.org/10.1016/j.mgene.2018.08.013.
Kadali, S., S. M. Naushad, A. Radha Rama Devi, and V. L. Bodiga. 2019.Biochemical, Machine Learning and Molecular Approaches for the Differential Diagnosis of Mucopolysaccharidoses . Vol. 458.
Kamranjam, M., and M. Alaei. 2019. “Mutation Analysis of the IDUA Gene in Iranian Patients with Mucopolysaccharidosis Type 1: Identification of Four Novel Mutations.” Genetic Testing and Molecular Biomarkers23(8):515–22. doi: 10.1089/gtmb.2019.0022 [doi].
Kantaputra, P. N., H. Kayserili, Y. Guven, W. Kantaputra, M. C. Balci, P. Tanpaiboon, N. Tananuvat, A. Uttarilli, and A. Dalal. 2014. “Clinical Manifestations of 17 Patients Affected with Mucopolysaccharidosis Type VI and Eight Novel ARSB Mutations.”American Journal of Medical Genetics.Part A 164A(6):1443–53. doi: 10.1002/ajmg.a.36489 [doi].
Khan, S. A., H. Peracha, D. Ballhausen, A. Wiesbauer, M. Rohrbach, M. Gautschi, R. W. Mason, R. Giugliani, Y. Suzuki, K. E. Orii, T. Orii, and S. Tomatsu. 2017. “Epidemiology of Mucopolysaccharidoses.”Molecular Genetics and Metabolism 121(3):227–40. doi: S1096-7192(17)30206-8 [pii].
Khorrami, Mehdi, Manijeh Mahdavi, Fatemeh Fakhr, and Majid Kheirollahi. 2019. “In Silico Analysis of A Novel Pathogenic Variant in an Iranian Mucopolysaccharidosis IIIB Patient Identified by Targeted Next-Generation Sequencing.” Iranian Journal of Child Neurology13(4):173–83. doi: 10.22037/ijcn.v13i4.19894.
Laradi, S., T. Tukel, M. Erazo, J. Shabbeer, L. Chkioua, S. Khedhiri, S. Ferchichi, M. Chaabouni, A. Miled, and R. J. Desnick. 2005. “Mucopolysaccharidosis I: Alpha-L-Iduronidase Mutations in Three Tunisian Families.” Journal of Inherited Metabolic Disease28(6):1019–26. doi: 10.1007/s10545-005-0197-4 [doi].
Malekpour, Nasrin, Rahim Vakili, and Tayebeh Hamzehloie. 2018. “Mutational Analysis of ARSB Gene in Mucopolysaccharidosis Type VI: Identification of Three Novel Mutations in Iranian Patients.”Iranian Journal of Basic Medical Sciences 21(9):950–56. doi: 10.22038/IJBMS.2018.27742.6760.
Mansour, Salehi, Salehi Rasoul, and Nasr Esfahani B. 2007. “MOLECULAR DETECTION AND IDENTIFICATION OF ALFA- L-IDURONIDASE GENE MUTATIONSJN 5 IRANIAN FAMILIES SUSPECTED FOR MULLER SYNDROME (MUCOPOLYSACCHARIDOSIS I).” 15(2):57–63.
Martin, R., M. Beck, C. Eng, R. Giugliani, P. Harmatz, V. Munoz, and J. Muenzer. 2008. “Recognition and Diagnosis of Mucopolysaccharidosis II (Hunter Syndrome).” Pediatrics 121(2):377. doi: 10.1542/peds.2007-1350 [doi].
Martins, Carla, Paula Frassinetti V. de Medeiros, Sandra Leistner‐Segal, Larbi Dridi, Nursel Elcioglu, Jill Wood, Mahdiyeh Behnam, Bilge Noyan, Lucia Lacerda, Michael T. Geraghty, Damian Labuda, Roberto Giugliani, and Alexey V. Pshezhetsky. 2019. “Molecular Characterization of a Large Group of Mucopolysaccharidosis Type IIIC Patients Reveals the Evolutionary History of the Disease.” Human Mutation40(8):1084–1100. doi: https://doi.org/10.1002/humu.23752.
Montano, A. M., N. Lock-Hock, R. D. Steiner, B. H. Graham, M. Szlago, R. Greenstein, M. Pineda, A. Gonzalez-Meneses, M. Coker, D. Bartholomew, M. S. Sands, R. Wang, R. Giugliani, A. Macaya, G. Pastores, A. K. Ketko, F. Ezgu, A. Tanaka, L. Arash, M. Beck, R. E. Falk, K. Bhattacharya, J. Franco, K. K. White, G. A. Mitchell, L. Cimbalistiene, M. Holtz, and W. S. Sly. 2016. “Clinical Course of Sly Syndrome (Mucopolysaccharidosis Type VII).” Journal of Medical Genetics 53(6):403–18. doi: 10.1136/jmedgenet-2015-103322 [doi].
Morrone, A., A. Caciotti, R. Atwood, K. Davidson, C. Du, P. Francis-Lyon, P. Harmatz, M. Mealiffe, S. Mooney, T. R. Oron, A. Ryles, K. A. Zawadzki, and N. Miller. 2014. “Morquio A Syndrome-Associated Mutations: A Review of Alterations in the GALNS Gene and a New Locus-Specific Database.” Human Mutation 35(11):1271–79. doi: 10.1002/humu.22635 [doi].
Mosallanejad, A., M. Alaei, S. R. Ghaffari, M. Rafati, and H. Saneifard. 2020. “Non-Progressive Nonimmune Hydrops Fetalis Caused by a Novel Mutation in GUSB Gene.” Iranian Journal of Child Neurology14(2):101–6. doi: jcn-14-101 [pii].
Muenzer, J., M. Beck, R. Giugliani, Y. Suzuki, A. Tylki-Szymanska, V. Valayannopoulos, A. Vellodi, and J. E. Wraith. 2011. “Idursulfase Treatment of Hunter Syndrome in Children Younger than 6 Years: Results from the Hunter Outcome Survey.” Genetics in Medicine : Official Journal of the American College of Medical Genetics 13(2):102–9. doi: 10.1097/GIM.0b013e318206786f [doi].
Muenzer, J., J. E. Wraith, L. A. Clarke, International Consensus Panel on Management, and I. Treatment of Mucopolysaccharidosis. 2009. “Mucopolysaccharidosis I: Management and Treatment Guidelines.”Pediatrics 123(1):19–29. doi: 10.1542/peds.2008-0416 [doi].
Northover, H., R. A. Cowie, and J. E. Wraith. 1996. “Mucopolysaccharidosis Type IVA (Morquio Syndrome): A Clinical Review.” Journal of Inherited Metabolic Disease 19(3):357–65. doi: 10.1007/BF01799267 [doi].
Nouri, Nayerossadat, Nargesossadat Nouri, Omid Aryani, Behnam Kamalidehghan, and Massoud Houshmand. 2012. “Identification of a Novel Arylsulfatase B Gene Mutation in Three Unrelated Iranian Mucopolysaccharidosis Type-VI Patients with Different Phenotype Severity.” Iranian Biomedical Journal 16(3):169–71. doi: 10.6091/ibj.1049.2012.
Papadimitriou, Sofia, Andrea Gazzo, Nassim Versbraegen, Charlotte Nachtegael, Jan Aerts, Yves Moreau, Sonia Van Dooren, Ann Nowé, Guillaume Smits, and Tom Lenaerts. 2019. “Predicting Disease-Causing Variant Combinations.” Proceedings of the National Academy of Sciences of the United States of America 116(24):11878–87. doi: 10.1073/pnas.1815601116.
Quail, M. A., I. Kozarewa, F. Smith, A. Scally, P. J. Stephens, R. Durbin, H. Swerdlow, and D. J. Turner. 2008. “A Large Genome Center’s Improvements to the Illumina Sequencing System.” Nature Methods5(12):1005–10. doi: 10.1038/nmeth.1270 [doi].
Regier, Debra S., Matthew Oetgen, and Pranoot Tanpaiboon. 1993. “Mucopolysaccharidosis Type IVA.” in GeneReviews® , edited by M. P. Adam, H. H. Ardinger, R. A. Pagon, S. E. Wallace, L. J. Bean, G. Mirzaa, and A. Amemiya. Seattle (WA): University of Washington, Seattle.
Salehi, R. 2004. “REPORT OF A NOVEL MUTATION IN Α-L-IDURONIDASE (IDUA) IN AN IRANIAN FAMILY WITH HURLER SYNDROME (MUCOPOLYSACCHARIDOSIS I).” 17(1):80–88.
Scarpa, M. 1993. “Mucopolysaccharidosis Type II.”GeneReviews((R)) , edited by M. P. Adam, H. H. Ardinger, R. A. Pagon, S. E. Wallace, L. J. H. Bean, K. Stephens, and A. Amemiya. Seattle (WA): University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.
Seyedhassani, Seyed Mohammad, Feyzollah Hashemi-Gorji, Mahdieh Yavari, and Reza Mirfakhraie. 2015. “Novel Missense Mutation in the GALNS Gene in an Affected Patient with Severe Form of Mucopolysaccharidosis Type IVA.” Clinica Chimica Acta 450:121–24. doi: https://doi.org/10.1016/j.cca.2015.08.006.
Shafaat, Seyed Mehdi, Mehrdad Hashemi, Ahmad Majd, Maryam Abiri, and Sirous Zeinali. 2020. “Genetic Assessment of Mucopolysaccharidosis Type IV and the First Pathological Mutation of c.313A>G in the Iranian Population.” The Horizon of Medical Sciences26(2):182–91. doi: 10.32598/hms.26.2.3275.1.
Stenson, Peter D., Matthew Mort, Edward V. Ball, Katy Shaw, Andrew Phillips, and David N. Cooper. 2014. “The Human Gene Mutation Database: Building a Comprehensive Mutation Repository for Clinical and Molecular Genetics, Diagnostic Testing and Personalized Genomic Medicine.”Human Genetics 133(1):1–9. doi: 10.1007/s00439-013-1358-4.
Taghikhani, Mohammad, Shohreh Khatami, Mohammad Abdi, Mohammad Said Hakhamaneshi, Mohammad Reza Alaei, Daniel Zamanfar, and Rahim Vakili. 2019. “Mutation Analysis and Clinical Characterization of Iranian Patients with Mucopolysaccharidosis Type I.” Journal of Clinical Laboratory Analysis 33(8):e22963. doi: https://doi.org/10.1002/jcla.22963.
Tomanin, R., L. Karageorgos, A. Zanetti, M. Al-Sayed, M. Bailey, N. Miller, H. Sakuraba, and J. J. Hopwood. 2018. “Mucopolysaccharidosis Type VI (MPS VI) and Molecular Analysis: Review and Classification of Published Variants in the ARSB Gene.” Human Mutation39(12):1788–1802. doi: 10.1002/humu.23613 [doi].
Tomatsu, S., M. Filocamo, K. O. Orii, W. S. Sly, M. A. Gutierrez, T. Nishioka, O. P. Serrato, P. Di Natale, A. M. Montano, S. Yamaguchi, N. Kondo, T. Orii, and A. Noguchi. 2004. “Mucopolysaccharidosis IVA (Morquio A): Identification of Novel Common Mutations in the N-Acetylgalactosamine-6-Sulfate Sulfatase (GALNS) Gene in Italian Patients.” Human Mutation 24(2):187–88. doi: 10.1002/humu.9265 [doi].
Tomatsu, S., A. M. Montano, H. Oikawa, M. Smith, L. Barrera, Y. Chinen, M. M. Thacker, W. G. Mackenzie, Y. Suzuki, and T. Orii. 2011. “Mucopolysaccharidosis Type IVA (Morquio A Disease): Clinical Review and Current Treatment.” Current Pharmaceutical Biotechnology12(6):931–45. doi: 1389-2010/11 $58.00+.00 [doi].
Valstar, M. J., S. Neijs, H. T. Bruggenwirth, R. Olmer, G. J. Ruijter, R. A. Wevers, O. P. van Diggelen, B. J. Poorthuis, D. J. Halley, and F. A. Wijburg. 2010. “Mucopolysaccharidosis Type IIIA: Clinical Spectrum and Genotype-Phenotype Correlations.” Annals of Neurology68(6):876–87. doi: 10.1002/ana.22092 [doi].
Valstar, Marlies J., Aida Bertoli-Avella, Marja W. Wessels, George J. G. Ruijter, Bianca de Graaf, Renske Olmer, Peter Elfferich, Sanne Neijs, Roxana Kariminejad, Fatih Suheyl Ezgü, Aysegul Tokatli, Barbara Czartoryska, Ad N. Bosschaart, Feikje van den Bos-Terpstra, Hugues Puissant, Friederike Bürger, Heymut Omran, D. Eckert, Mirella Filocamo, Emil Simeonov, Patrick J. Willems, Ron A. Wevers, Martinus F. Niermeijer, Dicky J. J. Halley, Ben J. H. M. Poorthuis, and Otto P. van Diggelen. 2010. “Mucopolysaccharidosis Type IIID: 12 New Patients and 15 Novel Mutationsb.” Human Mutation 31(5):E1348–60. doi: https://doi.org/10.1002/humu.21234.
Wang, Z., W. Zhang, Y. Wang, Y. Meng, L. Su, H. Shi, and S. Huang. 2010. “Mucopolysaccharidosis IVA Mutations in Chinese Patients: 16 Novel Mutations.” Journal of Human Genetics 55(8):534–40. doi: 10.1038/jhg.2010.65 [doi].
Wood, T. C., K. Harvey, M. Beck, M. G. Burin, Y. H. Chien, H. J. Church, V. D’Almeida, O. P. van Diggelen, M. Fietz, R. Giugliani, P. Harmatz, S. M. Hawley, W. L. Hwu, D. Ketteridge, Z. Lukacs, N. Miller, M. Pasquali, A. Schenone, J. N. Thompson, K. Tylee, C. Yu, and C. J. Hendriksz. 2013. “Diagnosing Mucopolysaccharidosis IVA.” Journal of Inherited Metabolic Disease 36(2):293–307. doi: 10.1007/s10545-013-9587-1 [doi].
Yassaee, Vahid Reza, Feyzollah Hashemi-Gorji, Mohammad Miryounesi, Alireza Rezayi, Zeinab Ravesh, Fakhrolmolouk Yassaee, and Shadab Salehpour. 2017. “Clinical, Biochemical and Molecular Features of Iranian Families with Mucopolysaccharidosis: A Case Series.”Clinica Chimica Acta 474:88–95. doi: https://doi.org/10.1016/j.cca.2017.08.017.